Isracann Closer to Greenhouse Construction as Israel Cannabis Market Heats Up
Ash Stringer
December 10th, 2019
App, Exclusive, News, Top Story
Israel has long been recognized for its pioneering contributions to research in the medical cannabis field. Recently, the state made its commitment clear to develop the sector by issuing a white paper on the opportunity to invest in Israeli cannabis. That was followed by the largest medical-marijuana merger ever in the country, with Cannbit Pharmaceuticals buying Tikun Olam’s Israel operations for up to $41.5 million, as excitement percolates over the underserved domestic market and upcoming cannabis exports.
In April, the Israeli government became only the third country in the world to legalize medical cannabis exports with expectations for the framework to be in place in 2020. The country is following in the footsteps of Canada, which witnessed its medical marijuana exports triple in 2018.
A supportive government, a rich cannabis technology history, upcoming exports and nearly perfect climate for greenhouse cannabis cultivation were enough to incentivize Isracann Biosciences (CSE: IPOT) (OTC: ISCNF) to set up operations in Israel. Led by a management team that has decades of combined experience in the legal Canadian markets, Isracann is fully funded for a 230,000 square-foot facility in southern Israel with annual capacity up to 23,500 kilograms of dried cannabis flower.
Click Here To Receive Isracann’s Investor Presentation
In the last week of November, Isracann management checked another box to move closer to construction of the facility.
Maintaining High Standards
One of the benefits of maneuvering through cannabis legalization across Canada for the last decade is Isracann management knows to be meticulous in moving forward. To that point, the company retained the cannabis and agronomy experts at LinC, a unit of LinC Grow Smart Ltd, architecture firm AgroPlan Ltd.and security company A.R. Factor Group to ensure the planned facility is designed and built to meet or exceed the complete gamut of industry, regulatory and environmental standards.
With intentions to supply both the Israeli and European markets in the future, Isracann plans to secure Israeli Medical Cannabis Good Agricultural Practices (IMC-GAP), Israeli Medical Cannabis Good Security Practices (IMC-GSP) and European Union Good Manufacturing Practices (EU-GMP) certifications for its cultivation and post-production facilities.
Moving Right Along
As should be expected, it’s a bit of a byzantine pathway to licensing and permitting a cannabis operation. With the help of LinC, AgroPlan and A.R. Factor, Isracann has expedited submissions to move forward with the facility, including submitting architectural, agronomic and security plans to the Israeli Land Authority about two weeks ago.
Now the company has received the facility design and land use approvals from the Israeli Land Authority necessary for construction permitting and awarding building contracts for the first phase of the 230,000 square-foot facility. Isracann already vetted proposals from domestic and international companies bidding on the project. Approvals are pending from the Israeli Settlement Commissioner and the Israeli Ministry of Health in order to begin construction.
Click Here To Receive Isracann’s Investor Presentation
“With this approval in place we have met the initial hurdles regarding land use. Now, we can get started with the next step of getting shovels in the ground and begin building our business,” commented Isracann CEO Darryl Jones in a news release.
The Facility
The plans call for the greenhouse to be built in Nir, Israel, a small cooperative agricultural community called a moshav. Phase I involves the fabrication of two greenhouses up to 57,500 square-feet each (for a total of 115,000 square feet) with estimated annual capacity of 5,750 kilograms (11,500 kg combined) of dried cannabis flower.
Each greenhouse will feature a highly ventilated framework with curtains on all four sides of the vaulted roof configuration. The roof design utilizes polyethylene sheets specifically installed for cannabis cultivation in Israel that maximizes the unique sunlight exposure in the country. Three types of fans will be used as part of the cooling and ventilation system to assist in optimizing temperature, humidity and radiation throughout the facility.
A packing facility includes a 6,500 square-foot post-harvest area with drying, curing and trimming rooms, as well as office space and a kitchen for employees.
The entire facility will be secured by an 8’ tall fence with an electronic gate for vehicle access and a closed-circuit television system.
Click Here To Receive Isracann’s Investor Presentation
To learn more about Isracann Biosciences Click Here
Click Here to Receive CFN Media’s Newsletter Every Week in Your Inbox
Disclaimer
CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on https://cannabisfn.com(the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ash Stringer
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Matthew Nordgren is an ambitious executive, dedicated philanthropist, and accomplished athlete who brings a unique passion to creating strategic alliances. He has breadth and depth of experience in finance, corporate development, and capital sourcing, as well as in building highly motivated teams of skilled professionals. In 2005, Mr. Nordgren received his education at the University […]
Matt Hawkins is the founder and managing principal of Cresco Capital Partners, LLC (“Cresco”), a private equity firm focused specifically on investing in the legalized cannabis industry. Since its inception in the summer of 2015, Cresco has made 14 investments out of its first fund and is currently raising this fund, Fund II. Prior to the […]
Fiore Cannabis (CSE:FIOR) (OTCQX:FIORF) is a publicly-traded company that has been investing in the development of medical and recreational cannabis products since 2014.
JWC is a Licensed Producer under the ACMPR with the goal of helping patients by providing clean, consistent medical cannabis products.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
